SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds shares sold off after management warned that elevated inflation and weak restaurant traffic could persist, while its long-term growth strategy and planned franchisee support raised concerns about spending and near-term returns. Traders debated whether the decline was an overreaction and a buying opportunity or a sign that high prices and softer consumer demand are weighing on the business.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Vikings proposed stock and convertible-note financing is driving debate after encouraging VK2735 obesity-drug maintenance data: critics say the raise could dilute shareholders and disrupt momentum, while supporters argue it funds development and commercialization and strengthens the companys negotiating position. Traders also remain focused on the drugs potential in the competitive obesity market, with short-squeeze speculation amid volatile trading.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys first Alloy Kore design win, selected by Coreturaa venture founded by Daimler Truck and Volvo Grouphas drawn attention alongside the upcoming quarterly report; the deal adds a significant estimated royalty backlog and marks QNXs largest design win. Many traders see it as validation of QNXs growth potential, while skeptics question how quickly the backlog will translate into revenue and want the earnings report to demonstrate execution and clear guidance.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

An FDA advisory panel voted in favor of GRAILs Galleri multi-cancer blood test, prompting bullish reactions and speculation about short covering. Traders also note that the panel recommendation is nonbinding and that final FDA approval, labeling, and reimbursement remain uncertain.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unitys strong Q2 results and upbeat outlook, driven by accelerating Vector-powered advertising growth, are fueling attention, alongside analyst upgrades and optimism about the companys turnaround. Traders are bullish on the growth and AI opportunity, though some point to volatility, recent gains, and uncertainty about how much market share Unity is taking from AppLovin.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

An Edgewater Research warning that AppLovins MAX ad network may be nearing a market-share ceiling, with competition pressuring revenue spreads and growth, is driving concern around the stocks decline. Traders dispute the bearish viewsome see a buying opportunity and point to Citis report of accelerating e-commerce client growth, while others worry that growth is stalling.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

An FDA alert involving GLP-1 drugs and concerns about regulatory scrutiny of Hims & Hers weight-loss offerings are weighing on sentiment, with traders saying the risks overshadow Australia expansion. The community is divided between concern about compliance and the companys growth prospects in weight loss and peptides; no listed article directly verifies the discussion.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFis launch of stablecoin settlement across Mastercards payments network is the main catalyst, with traders weighing its potential to expand SoFiUSDs payments business. Many are frustrated that the initial share-price pop faded, calling it a sell-the-news move or blaming short pressure, while others see longer-term upside in the partnership.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Metas Muse AI assistant is drawing attention after early App Store traction, with traders also watching Meta Connect and new commerce integrations as signs of potential adoption and monetization. Bulls see a promising consumer-AI growth story, while skeptics question its staying power, privacy and revenue potential; after a sharp rally, profit-taking and overbought concerns are also prominent.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Auroras investor-day roadmap targeting 30,000 driverless trucks by 2030 and scaling production is the main focus, but the stock is drawing a mixed reaction: bullish traders point to commercial growth and improving economics, while skeptics see an ambitious, long-dated plan with limited near-term traction. Traders also cite ongoing share-sale overhang, including Ubers disposals, as pressure on the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GRAILs Galleri cancer blood test is drawing attention after an FDA advisory panel voted that its benefits outweigh its risks, despite a closer vote on effectiveness; the panels recommendation is not a final FDA approval. Traders are largely treating the outcome as a win, while debating the implications for labeling, coverage and the stocks sharp moves.

GRAL Stock Clocks Best Day In Over 1.5 Years — FDA Papers Lift Galleri Approval Hopes

Equity

Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will meet on Sept. 23 to discuss Grail’s application seeking approval of its cancer detection test. 

FDA Decision Watch: MRK, MIRM, INCY, GRAL Face Key Regulatory Catalysts This Week 

Merck, Mirum, Incyte and Grail are in focus this week as investors await key FDA decisions and a regulatory review involving treatments for lung disease, a rare bone disorder and cancer detection.


GRAIL Q2 2026 Earnings Call: Complete Transcript

On Wednesday, GRAIL (NASDAQ:GRAL) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensive financial dataread more...

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire SUNNYVALE, Calif., Sept. 3, 2026 SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission...

GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference

GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference PR Newswire MENLO PARK, Calif., Aug. 31, 2026 MENLO PARK, Calif., Aug. 31, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare...

GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test

GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test PR Newswire MENLO PARK...

GRAIL Reports Second Quarter 2026 Financial Results

GRAIL Reports Second Quarter 2026 Financial Results GRAIL Reports Second Quarter 2026 Financial Results PR Newswire MENLO PARK, Calif., Aug. 5, 2026 Q2 Galleri Test Volume Increased 35% to More Than 61,000 Year-Over-Year, and Galleri Revenue Grew 24% to $42.6 Million Galleri Test Volume and Revenue...

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Grail, Inc. (Grail or the Company) (NASDAQ: GRAL) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed...

GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm

GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm PR Newswire...

GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire SAN FRANCISCO, Aug. 4, 2026 SAN FRANCISCO, Aug. 4, 2026...

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Microsoft Corp

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

SpaceX

Stocktwits Polls

Traders are closely monitoring the advisory panel's critical review of the Galleri cancer test, with sentiment split on potential approval.

Investor anticipation is building around a positive FDA verdict, fueling talk of long-term price targets and market breakthroughs.

Market participants are debating the high short interest levels and the possibility of a violent price surge following the regulatory event.

Current Price	$108.52
Prev Close	$107.97
Open	$106.75
Dividend Yield	0.00%
50-Day Moving Average	$75.41
Beta	2.42
Avg. Volume	771,152.16
PE Ratio	-11.13

52-Week High	$118.84
52-Week Low	$41.50
Market Capitalization	$4.85B
EPS (Annual)	-$11.11
Price to Book	1.91
Revenue Per Employee	$161,727.47

Feed

News

Sentiment

Earnings

Fundamentals

Info

GRAL Fundamentals